EFEMP1 and liver cancer: When liver-related events were analyzed separately for liver cancer and decompensation, patients with high serum Fibulin-3 levels (>6.0 μg/mL) developed each event at a significantly greater rate than patients with low serum Fibulin-3 levels (<6.0 μg/mL) (Supplemental Figure S4A, http://links.lww.com/HC9/A893, Supplemental Figure S4B, http://links.lww.com/HC9/A893).